$1.98
-0.06-2.94%
After Hours: 9:25 AM EDT
15 minutes delayed
ZyVersa Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of ZyVersa Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-09 | $-3.31 | $-3.75 | 11.7 % |
Mar 2024 | 2024-05-15 | $-4.53 | $-3.70 | -22.4 % |
Dec 2023 | 2024-03-25 | $-0.25 | $-42.80 | 99.4 % |
Sep 2023 | 2023-11-14 | $-63.00 | $-112.00 | 43.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
ZyVersa Therapeutics (ZVSA) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on August 9, 2024 for Q2.
The Actual EPS was $-3.31, which beat the estimate of $-3.75.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.